Adherence to glucocorticoid replacement therapy in Addison's disease: Association with patients' disease knowledge and quality of life

Little is known about the quality of adherence to glucocorticoid replacement therapy in patients with Addison disease (AD). The aim of this study was to evaluate the quality of glucocorticoid treatment adherence in patients with AD and to assess its association with patients' disease knowledge and quality of life.Methods: This is a cross-sectional study including 58 patients with AD. The Girerd questionnaire was used to assess the quality of adherence to glucocorticoid replacement therapy. A questionnaire was specially designed to assess patients' disease knowledge. The AddiQol questionnaire, specific to AD, was used to assess the patients' quality of life. Patients were considered non adherent if they gave three or fewer than three negative answers to the Girerd questionnaire (score <= 3/6).Results: The mean age of the patients was 48.4 +/- 13.3 years (39 women and 19 men). Twentyseven patients (46%) were non-adherent to glucocorticoid replacement therapy. An age below 48 years, poor adherence to comorbidity treatments, baseline cortisolemia at diagnosis > 5 mu g/dl, history of adrenal crisis, poor knowledge about the disease, BMI < 26.7 kg/m(2), waist circumference < 90 cm, low systolic blood pressure, fasting blood glucose < 0.9 g/l, and triglyceride < 1 g/l were the factors independently associated with non-adherence (respectively ORa [CI 95%] = 4.8 [2.8-10.7], 5.0 [3.0-12.2], 2.3 [1.2-6.2], 4.1 [2.0--8.3], 3.9 [1.2-7.2], 3.9 [1.1-6.9], 1.8 [1.1-2.9], 4.8 [2.6--8.2], 2.5 [1.1-5.3], and 2.2 [1.1-5.1]). There was a positive correlation between the disease knowledge questionnaire score and the Girerd score (p = 0.02, r = 0.31). There was a positive correlation between the AddiQoL score and the Girerd score (p = 0.01, r = 0.32).Conclusion: Non-adherence to glucocorticoid replacement therapy was common in patients with AD and was associated with more frequent adrenal crisis and poorer quality of life. The quality of treatment adherence was correlated with patients' disease knowledge. Therapeutic education is essential to reduce the frequency of non-adherence, especially among young patients.(c) 2023 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.